The global allergy diagnostics and therapeutics market size was estimated at USD 58.31 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2030. Increasing incidences of allergic diseases, coupled with demand for advanced therapeutics, is expected to drive the market growth in the coming years. According to estimates published by the American Academy of Allergy Asthma & Immunology (AAAAI), allergic rhinitis affects approximately 10-30% of the global population, thereby impacting the adoption of allergy therapeutics globally. ![Global Allergy Diagnostics and Therapeutics Market]( "Global Allergy Diagnostics and Therapeutics Market")
The increasing integration of technologically advanced products, such as the use of artificial intelligence technology to advance treatment outcomes and manage diseases, helps practitioners in the decision-making process. Furthermore, the rising adoption of mHealth apps for diagnosing allergies such as rhinitis is expected to boost the market. For instance, the MASK-Air app is dedicated specifically to allergic rhinitis.
Monoclonal antibodies are anticipated to contribute to the development of new therapies that eradicate specific allergy concerns, owing to their higher efficacy, long-term tolerability, and safety. Hence, key companies are developing novel & effective biologic-based therapies designed with target-specific mechanisms directed toward selective targets, especially monoclonal antibodies. In addition, consistent product approvals of highly significant monoclonal antibodies for allergy disorders are anticipated to expand the scope for growth.
New therapies such as anti-immunoglobulin E (IgE) antibodies, cytokine modulators, and DNA vaccinations are being used to treat allergic disorders. Omalizumab is a recombinant humanized IgG1 monoclonal anti-IgE antibody, which is used for treating allergic chronic urticaria and asthma. In April 2021, Genentech (Roche Group) announced that its prefilled syringe for self-injection has received FDA approval for Xolair (omalizumab) in the U.S. for chronic idiopathic urticaria allergic asthma, and nasal polyps.
The allergy diagnostics & therapeutics market is moderately competitive, with a strong presence of notable companies such as Merck & Co., Inc, Thermo Fisher Scientific, Inc., Abbott, and Pfizer, Inc. These players are undertaking various initiatives to increase their capabilities, expand their product portfolios, and improve their competencies.
This product will be delivered within 2 business days.
The increasing integration of technologically advanced products, such as the use of artificial intelligence technology to advance treatment outcomes and manage diseases, helps practitioners in the decision-making process. Furthermore, the rising adoption of mHealth apps for diagnosing allergies such as rhinitis is expected to boost the market. For instance, the MASK-Air app is dedicated specifically to allergic rhinitis.
Monoclonal antibodies are anticipated to contribute to the development of new therapies that eradicate specific allergy concerns, owing to their higher efficacy, long-term tolerability, and safety. Hence, key companies are developing novel & effective biologic-based therapies designed with target-specific mechanisms directed toward selective targets, especially monoclonal antibodies. In addition, consistent product approvals of highly significant monoclonal antibodies for allergy disorders are anticipated to expand the scope for growth.
New therapies such as anti-immunoglobulin E (IgE) antibodies, cytokine modulators, and DNA vaccinations are being used to treat allergic disorders. Omalizumab is a recombinant humanized IgG1 monoclonal anti-IgE antibody, which is used for treating allergic chronic urticaria and asthma. In April 2021, Genentech (Roche Group) announced that its prefilled syringe for self-injection has received FDA approval for Xolair (omalizumab) in the U.S. for chronic idiopathic urticaria allergic asthma, and nasal polyps.
The allergy diagnostics & therapeutics market is moderately competitive, with a strong presence of notable companies such as Merck & Co., Inc, Thermo Fisher Scientific, Inc., Abbott, and Pfizer, Inc. These players are undertaking various initiatives to increase their capabilities, expand their product portfolios, and improve their competencies.
Allergy Diagnostics And Therapuetics Market Report Highlights
- The consumables product segment held the largest share in the allergy diagnostics & therapeutics market in 2022. The advent of products that include the MeDALL allergen-chip, which is linked with increased sensitivity, precision, and faster detection, is anticipated to encourage market growth
- The drug allergies segment is expected to advance lucratively due to the increasing availability of treatment options and growing awareness about drug allergies among patients
- In vitro tests accounted for the highest share in 2022 due to an increase in the incidence of allergies such as asthma, rhinitis, & allergic conjunctivitis, and a rise in demand for allergy testing globally
- Epinephrine dominated the drug class segment in 2022. The introduction of cost-effective epinephrine autoinjectors by key companies is expected to significantly augment market growth
- North America dominated the allergy diagnostics & therapeutics market in 2022, due to an increase in understanding of the high potential associated with allergy drugs. This has driven U.S.-based firms to make considerable investments in the development of these drugs
- Asia-Pacific is expected to witness considerable growth in the future owing to the rising incidences of asthma, chronic cough, and food allergies, among others, in the region
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.5.1. Commodity Flow Analysis
1.5.1.1. Approach 1: Commodity flow approach
1.5.1.2. Approach 2: Country-wise market estimation using bottom-up approach
1.6. Data Validation & Publishing
1.7. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.2. Market Definitions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.5.1. Commodity Flow Analysis
1.5.1.1. Approach 1: Commodity flow approach
1.5.1.2. Approach 2: Country-wise market estimation using bottom-up approach
1.6. Data Validation & Publishing
1.7. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
2.2. Segmental Snapshot
2.3. Competitive Insights Snapshot
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage
3.1.1. Parent Market Analysis
3.1.2. Ancillary Market Analysis
3.2. Allergy Diagnostics & Therapeutics Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of allergies
3.2.1.2. Advancements in technology and launch of new products
3.2.1.3. High adoption of immunotherapy drugs
3.2.2. Market Restraint Analysis
3.2.2.1. Low adoption and penetration in developing countries due to the high cost of technology
3.2.2.2. Lack of allergen standardization
3.3. Business Environmental Tools Analysis: Allergy Diagnostics & Therapeutics Market
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Pipeline Analysis
3.1.1. Parent Market Analysis
3.1.2. Ancillary Market Analysis
3.2. Allergy Diagnostics & Therapeutics Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of allergies
3.2.1.2. Advancements in technology and launch of new products
3.2.1.3. High adoption of immunotherapy drugs
3.2.2. Market Restraint Analysis
3.2.2.1. Low adoption and penetration in developing countries due to the high cost of technology
3.2.2.2. Lack of allergen standardization
3.3. Business Environmental Tools Analysis: Allergy Diagnostics & Therapeutics Market
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Pipeline Analysis
Chapter 4. Allergy Diagnostics & Therapeutics Market: Type Estimates & Trend Analysis
4.1. Allergy Diagnostics & Therapeutics Market, By Type: Key Takeaways
4.2. Allergy Diagnostics & Therapeutics Market: Type Movement & Market Share Analysis, 2023 & 2030
4.3. Diagnostics
4.3.1. Global Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
4.3.2. Instruments
4.3.2.1. Global Instruments Market Estimates And Forecasts, 2018-2030 (USD Million)
4.3.3. Consumables
4.3.3.1. Global Consumables Market Estimates And Forecasts, 2018-2030 (USD Million)
4.3.4. Services
4.3.4.1. Global Services Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4. Therapeutics
4.4.1. Global Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.2. Antihistamines
4.4.2.1. Global Antihistamines Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.3. Decongestants
4.4.3.1. Global Decongestants Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.4. Corticosteroids
4.4.4.1. Global Corticosteroids Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.5. Mast Cell Stabilizers
4.4.5.1. Global Mast Cell Stabilizers Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.6. Leukotriene Inhibitors
4.4.6.1. Global Leukotriene Inhibitors Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.7. Nasal Anti-cholinergic
4.4.7.1. Global Nasal Anti-cholinergic Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.8. Immuno-modulators
4.4.8.1. Global Immuno-modulators Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.9. Epinephrine
4.4.9.1. Global Epinephrine Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.10. Immunotherapy
4.4.10.1. Global Immunotherapy Market Estimates And Forecasts, 2018-2030 (USD Million)
4.2. Allergy Diagnostics & Therapeutics Market: Type Movement & Market Share Analysis, 2023 & 2030
4.3. Diagnostics
4.3.1. Global Diagnostics Market Estimates And Forecasts, 2018-2030 (USD Million)
4.3.2. Instruments
4.3.2.1. Global Instruments Market Estimates And Forecasts, 2018-2030 (USD Million)
4.3.3. Consumables
4.3.3.1. Global Consumables Market Estimates And Forecasts, 2018-2030 (USD Million)
4.3.4. Services
4.3.4.1. Global Services Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4. Therapeutics
4.4.1. Global Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.2. Antihistamines
4.4.2.1. Global Antihistamines Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.3. Decongestants
4.4.3.1. Global Decongestants Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.4. Corticosteroids
4.4.4.1. Global Corticosteroids Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.5. Mast Cell Stabilizers
4.4.5.1. Global Mast Cell Stabilizers Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.6. Leukotriene Inhibitors
4.4.6.1. Global Leukotriene Inhibitors Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.7. Nasal Anti-cholinergic
4.4.7.1. Global Nasal Anti-cholinergic Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.8. Immuno-modulators
4.4.8.1. Global Immuno-modulators Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.9. Epinephrine
4.4.9.1. Global Epinephrine Market Estimates And Forecasts, 2018-2030 (USD Million)
4.4.10. Immunotherapy
4.4.10.1. Global Immunotherapy Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 5. Allergy Diagnostics & Therapeutics Market: Allergen Type Estimates & Trend Analysis
5.1. Allergy Diagnostics & Therapeutics Market, By Allergen type: Key Takeaways
5.2. Allergy Diagnostics & Therapeutics Market: Allergen type Movement & Market Share Analysis, 2023 & 2030
5.3. Food
5.3.1. Global Food Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.2. Dairy Products
5.3.2.1. Global Dairy Products Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.3. Poultry Product
5.3.3.1. Global Poultry Products Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.4. Tree Nuts
5.3.4.1. Global Tree Nuts Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.5. Peanuts
5.3.5.1. Global Peanut Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.6. Shellfish
5.3.6.1. Global Shellfish Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.7. Wheat
5.3.7.1. Global Wheat Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.8. Soy
5.3.8.1. Global Soy Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.9. Other Food Allergens
5.3.9.1. Global Food Allergens Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4. Inhaled
5.4.1. Global Inhaled Market Estimates And Forecasts, 2018-2030 (USD Million)
5.5. Drug
5.5.1. Global Drug Market Estimates And Forecasts, 2018-2030 (USD Million)
5.6. Others allergen types
5.6.1. Global Other allergen types Market Estimates And Forecasts, 2018-2030 (USD Million)
5.2. Allergy Diagnostics & Therapeutics Market: Allergen type Movement & Market Share Analysis, 2023 & 2030
5.3. Food
5.3.1. Global Food Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.2. Dairy Products
5.3.2.1. Global Dairy Products Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.3. Poultry Product
5.3.3.1. Global Poultry Products Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.4. Tree Nuts
5.3.4.1. Global Tree Nuts Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.5. Peanuts
5.3.5.1. Global Peanut Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.6. Shellfish
5.3.6.1. Global Shellfish Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.7. Wheat
5.3.7.1. Global Wheat Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.8. Soy
5.3.8.1. Global Soy Allergy Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.9. Other Food Allergens
5.3.9.1. Global Food Allergens Market Estimates And Forecasts, 2018-2030 (USD Million)
5.4. Inhaled
5.4.1. Global Inhaled Market Estimates And Forecasts, 2018-2030 (USD Million)
5.5. Drug
5.5.1. Global Drug Market Estimates And Forecasts, 2018-2030 (USD Million)
5.6. Others allergen types
5.6.1. Global Other allergen types Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 6. Allergy Diagnostics Market: Test Type Estimates & Trend Analysis
6.1. Allergy Diagnostics Market, By Test Type: Key Takeaways
6.2. Allergy Diagnostics Market: Test Type Movement & Market Share Analysis, 2023 & 2030
6.3. In Vivo tests
6.3.1. Global In Vivo tests Market Estimates And Forecasts, 2018-2030 (USD Million)
6.3.2. Skin Prick Test
6.3.2.1. Global Skin Prick Test Market Estimates And Forecasts, 2018-2030 (USD Million)
6.3.3. Intradermal Test
6.3.3.1. Global Intradermal Test Market Estimates And Forecasts, 2018-2030 (USD Million)
6.3.4. Patch Test
6.3.4.1. Global Patch Test Market Estimates And Forecasts, 2018-2030 (USD Million)
6.4. In Vitro tests
6.4.1. Global In Vitro tests Market Estimates And Forecasts, 2018-2030 (USD Million)
6.2. Allergy Diagnostics Market: Test Type Movement & Market Share Analysis, 2023 & 2030
6.3. In Vivo tests
6.3.1. Global In Vivo tests Market Estimates And Forecasts, 2018-2030 (USD Million)
6.3.2. Skin Prick Test
6.3.2.1. Global Skin Prick Test Market Estimates And Forecasts, 2018-2030 (USD Million)
6.3.3. Intradermal Test
6.3.3.1. Global Intradermal Test Market Estimates And Forecasts, 2018-2030 (USD Million)
6.3.4. Patch Test
6.3.4.1. Global Patch Test Market Estimates And Forecasts, 2018-2030 (USD Million)
6.4. In Vitro tests
6.4.1. Global In Vitro tests Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 7. Allergy Diagnostics & Therapeutics Market: Regional Estimates & Trend Analysis
7.1. Allergy Diagnostics & Therapeutics Market: Regional Movement Analysis, 2023 & 2030
7.2. North America
7.2.1. North America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Prevalence Insights
7.2.2.4. Regulatory Framework
7.2.2.5. Reimbursement Structure
7.2.2.6. U.S. Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Prevalence Insights
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Structure
7.2.3.6. Canada Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3. Europe
7.3.1. Europe Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Prevalence Insights
7.3.2.4. Regulatory Framework
7.3.2.5. Reimbursement Structure
7.3.2.6. UK Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Prevalence Insights
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Structure
7.3.3.6. Germany Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Prevalence Insights
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Structure
7.3.4.6. France Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Prevalence Insights
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Structure
7.3.5.6. Italy Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Prevalence Insights
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Structure
7.3.6.6. Spain Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Prevalence Insights
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Structure
7.3.7.6. Denmark Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Prevalence Insights
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Structure
7.3.8.6. Sweden Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Prevalence Insights
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Structure
7.3.9.6. Norway Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Prevalence Insights
7.4.2.4. Regulatory Framework
7.4.2.5. Reimbursement Structure
7.4.2.6. Japan Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Prevalence Insights
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Structure
7.4.3.6. China Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Prevalence Insights
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Structure
7.4.4.6. India Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Prevalence Insights
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Structure
7.4.5.6. Australia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Prevalence Insights
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Structure
7.4.6.6. Thailand Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Prevalence Insights
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Structure
7.4.7.6. South Korea Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Prevalence Insights
7.5.2.4. Regulatory Framework
7.5.2.5. Reimbursement Structure
7.5.2.6. Brazil Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Prevalence Insights
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Structure
7.5.3.6. Mexico Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Prevalence Insights
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Structure
7.5.4.6. Argentina Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6. Middle East & Africa
7.6.1. Middle East & Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Prevalence Insights
7.6.2.4. Regulatory Framework
7.6.2.5. Reimbursement Structure
7.6.2.6. South Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Prevalence Insights
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Structure
7.6.3.6. Saudi Arabia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Prevalence Insights
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Structure
7.6.4.6. UAE Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Prevalence Insights
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Structure
7.6.5.6. Kuwait Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.2. North America
7.2.1. North America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Prevalence Insights
7.2.2.4. Regulatory Framework
7.2.2.5. Reimbursement Structure
7.2.2.6. U.S. Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Prevalence Insights
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Structure
7.2.3.6. Canada Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3. Europe
7.3.1. Europe Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Prevalence Insights
7.3.2.4. Regulatory Framework
7.3.2.5. Reimbursement Structure
7.3.2.6. UK Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Prevalence Insights
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Structure
7.3.3.6. Germany Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Prevalence Insights
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Structure
7.3.4.6. France Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Prevalence Insights
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Structure
7.3.5.6. Italy Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Prevalence Insights
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Structure
7.3.6.6. Spain Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Prevalence Insights
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Structure
7.3.7.6. Denmark Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Prevalence Insights
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Structure
7.3.8.6. Sweden Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Prevalence Insights
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Structure
7.3.9.6. Norway Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4. Asia-Pacific
7.4.1. Asia-Pacific Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Prevalence Insights
7.4.2.4. Regulatory Framework
7.4.2.5. Reimbursement Structure
7.4.2.6. Japan Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Prevalence Insights
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Structure
7.4.3.6. China Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Prevalence Insights
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Structure
7.4.4.6. India Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Prevalence Insights
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Structure
7.4.5.6. Australia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Prevalence Insights
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Structure
7.4.6.6. Thailand Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Prevalence Insights
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Structure
7.4.7.6. South Korea Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Prevalence Insights
7.5.2.4. Regulatory Framework
7.5.2.5. Reimbursement Structure
7.5.2.6. Brazil Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Prevalence Insights
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Structure
7.5.3.6. Mexico Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Prevalence Insights
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Structure
7.5.4.6. Argentina Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6. Middle East & Africa
7.6.1. Middle East & Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Prevalence Insights
7.6.2.4. Regulatory Framework
7.6.2.5. Reimbursement Structure
7.6.2.6. South Africa Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Prevalence Insights
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Structure
7.6.3.6. Saudi Arabia Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Prevalence Insights
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Structure
7.6.4.6. UAE Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Prevalence Insights
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Structure
7.6.5.6. Kuwait Allergy Diagnostics & Therapeutics Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Company Market Share Analysis, 2023
8.3. Strategy Mapping
8.4. Company Profiles/Listing
8.4.1. R-Biopharm AG
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. EUROIMMUN Medizinische Labordiagnostika AG
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. DASIT Group SPA
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. AESKU.GROUP GmbH
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. bioMérieux
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Danaher
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Thermo Fisher Scientific, Inc
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Stallergenes Greer
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Minaris Medical America, Inc.
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Siemens Healthcare GmbH
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Omega Diagnostics Group PLC
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. HYCOR Biomedical
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
8.4.13. Lincoln Diagnostics, Inc.
8.4.13.1. Overview
8.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.13.3. Product Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. Alcon
8.4.14.1. Overview
8.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.14.3. Product Benchmarking
8.4.14.4. Strategic Initiatives
8.4.15. HOB Biotech Group Corp., Ltd.
8.4.15.1. Overview
8.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.15.3. Product Benchmarking
8.4.15.4. Strategic Initiatives
8.4.16. AbbVie Inc.
8.4.16.1. Overview
8.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.16.3. Product Benchmarking
8.4.16.4. Strategic Initiatives
8.4.17. Allergy Therapeutics
8.4.17.1. Overview
8.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.17.3. Product Benchmarking
8.4.17.4. Strategic Initiatives
8.4.18. Sanofi
8.4.18.1. Overview
8.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.18.3. Product Benchmarking
8.4.18.4. Strategic Initiatives
8.4.19. Pfizer Inc.
8.4.19.1. Overview
8.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.19.3. Product Benchmarking
8.4.19.4. Strategic Initiatives
8.4.20. Teva Pharmaceutical Industries Ltd.
8.4.20.1. Overview
8.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.20.3. Product Benchmarking
8.4.20.4. Strategic Initiatives
8.4.21. Sun Pharmaceutical Industries Ltd.
8.4.21.1. Overview
8.4.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.21.3. Product Benchmarking
8.4.21.4. Strategic Initiatives
8.4.22. GSK plc
8.4.22.1. Overview
8.4.22.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.22.3. Product Benchmarking
8.4.22.4. Strategic Initiatives
8.4.23. F. Hoffmann-La Roche Ltd.
8.4.23.1. Overview
8.4.23.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.23.3. Product Benchmarking
8.4.23.4. Strategic Initiatives
8.4.24. Merck & Co., Inc.
8.4.24.1. Overview
8.4.24.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.24.3. Product Benchmarking
8.4.24.4. Strategic Initiatives
8.4.25. Astellas Pharma Inc.
8.4.25.1. Overview
8.4.25.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.25.3. Product Benchmarking
8.4.25.4. Strategic Initiatives
8.2. Company Market Share Analysis, 2023
8.3. Strategy Mapping
8.4. Company Profiles/Listing
8.4.1. R-Biopharm AG
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. EUROIMMUN Medizinische Labordiagnostika AG
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. DASIT Group SPA
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. AESKU.GROUP GmbH
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. bioMérieux
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Danaher
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Thermo Fisher Scientific, Inc
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Stallergenes Greer
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Minaris Medical America, Inc.
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Siemens Healthcare GmbH
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Omega Diagnostics Group PLC
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. HYCOR Biomedical
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
8.4.13. Lincoln Diagnostics, Inc.
8.4.13.1. Overview
8.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.13.3. Product Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. Alcon
8.4.14.1. Overview
8.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.14.3. Product Benchmarking
8.4.14.4. Strategic Initiatives
8.4.15. HOB Biotech Group Corp., Ltd.
8.4.15.1. Overview
8.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.15.3. Product Benchmarking
8.4.15.4. Strategic Initiatives
8.4.16. AbbVie Inc.
8.4.16.1. Overview
8.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.16.3. Product Benchmarking
8.4.16.4. Strategic Initiatives
8.4.17. Allergy Therapeutics
8.4.17.1. Overview
8.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.17.3. Product Benchmarking
8.4.17.4. Strategic Initiatives
8.4.18. Sanofi
8.4.18.1. Overview
8.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.18.3. Product Benchmarking
8.4.18.4. Strategic Initiatives
8.4.19. Pfizer Inc.
8.4.19.1. Overview
8.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.19.3. Product Benchmarking
8.4.19.4. Strategic Initiatives
8.4.20. Teva Pharmaceutical Industries Ltd.
8.4.20.1. Overview
8.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.20.3. Product Benchmarking
8.4.20.4. Strategic Initiatives
8.4.21. Sun Pharmaceutical Industries Ltd.
8.4.21.1. Overview
8.4.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.21.3. Product Benchmarking
8.4.21.4. Strategic Initiatives
8.4.22. GSK plc
8.4.22.1. Overview
8.4.22.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.22.3. Product Benchmarking
8.4.22.4. Strategic Initiatives
8.4.23. F. Hoffmann-La Roche Ltd.
8.4.23.1. Overview
8.4.23.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.23.3. Product Benchmarking
8.4.23.4. Strategic Initiatives
8.4.24. Merck & Co., Inc.
8.4.24.1. Overview
8.4.24.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.24.3. Product Benchmarking
8.4.24.4. Strategic Initiatives
8.4.25. Astellas Pharma Inc.
8.4.25.1. Overview
8.4.25.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.25.3. Product Benchmarking
8.4.25.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Allergy Diagnostics & Therapeutics Market, By Region, 2018-2030 (USD Million)
Table 4 Global Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 5 Global Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 6 Global Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 7 Global Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 8 North America Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 9 North America Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 10 North America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 11 North America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 12 North America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 13 U.S. Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 14 U.S. Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 15 U.S. Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 16 U.S. Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 17 Canada Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 18 Canada Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 19 Canada Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 20 Canada Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 21 Europe Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 22 Europe Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 23 Europe Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 24 Europe Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 25 Europe Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 26 UK Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 27 UK Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 28 UK Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 29 UK Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 30 Germany Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 31 Germany Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 32 Germany Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 33 Germany Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 34 France Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 35 France Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 36 France Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 37 France Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 38 Italy Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 39 Italy Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 40 Italy Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 41 Italy Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 42 Spain Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 43 Spain Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 44 Spain Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 45 Spain Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 46 Denmark Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 47 Denmark Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 48 Denmark Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 49 Denmark Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 50 Sweden Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 51 Sweden Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 52 Sweden Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 53 Sweden Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 54 Norway Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 55 Norway Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 56 Norway Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 57 Norway Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 58 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 59 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 60 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 61 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 62 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 63 Japan Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 64 Japan Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 65 Japan Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 66 Japan Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 67 China Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 68 China Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 69 China Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 70 China Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 71 India Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 72 India Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 73 India Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 74 India Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 75 Australia Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 76 Australia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 77 Australia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 78 Australia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 79 South Korea Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 80 South Korea Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 81 South Korea Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 82 South Korea Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 83 Thailand Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 84 Thailand Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 85 Thailand Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 86 Thailand Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 87 Latin America Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 88 Latin America Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 89 Latin America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 90 Latin America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 91 Latin America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 92 Brazil Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 93 Brazil Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 94 Brazil Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 95 Brazil Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 96 Mexico Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 97 Mexico Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 98 Mexico Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 99 Mexico Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 100 Argentina Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 101 Argentina Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 102 Argentina Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 103 Argentina Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 104 MEA Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 105 MEA Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 106 MEA Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 107 MEA Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 108 MEA Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 109 South Africa Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 110 South Africa Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 111 South Africa Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 112 South Africa Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 113 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 114 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 115 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 116 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 117 UAE Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 118 UAE Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 119 UAE Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 120 UAE Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 121 Kuwait Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 122 Kuwait Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 123 Kuwait Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 124 Kuwait Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 2 List of Abbreviation
Table 3 Global Allergy Diagnostics & Therapeutics Market, By Region, 2018-2030 (USD Million)
Table 4 Global Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 5 Global Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 6 Global Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 7 Global Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 8 North America Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 9 North America Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 10 North America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 11 North America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 12 North America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 13 U.S. Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 14 U.S. Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 15 U.S. Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 16 U.S. Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 17 Canada Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 18 Canada Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 19 Canada Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 20 Canada Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 21 Europe Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 22 Europe Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 23 Europe Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 24 Europe Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 25 Europe Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 26 UK Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 27 UK Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 28 UK Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 29 UK Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 30 Germany Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 31 Germany Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 32 Germany Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 33 Germany Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 34 France Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 35 France Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 36 France Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 37 France Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 38 Italy Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 39 Italy Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 40 Italy Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 41 Italy Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 42 Spain Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 43 Spain Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 44 Spain Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 45 Spain Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 46 Denmark Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 47 Denmark Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 48 Denmark Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 49 Denmark Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 50 Sweden Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 51 Sweden Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 52 Sweden Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 53 Sweden Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 54 Norway Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 55 Norway Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 56 Norway Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 57 Norway Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 58 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 59 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 60 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 61 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 62 Asia-Pacific Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 63 Japan Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 64 Japan Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 65 Japan Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 66 Japan Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 67 China Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 68 China Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 69 China Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 70 China Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 71 India Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 72 India Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 73 India Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 74 India Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 75 Australia Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 76 Australia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 77 Australia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 78 Australia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 79 South Korea Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 80 South Korea Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 81 South Korea Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 82 South Korea Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 83 Thailand Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 84 Thailand Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 85 Thailand Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 86 Thailand Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 87 Latin America Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 88 Latin America Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 89 Latin America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 90 Latin America Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 91 Latin America Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 92 Brazil Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 93 Brazil Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 94 Brazil Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 95 Brazil Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 96 Mexico Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 97 Mexico Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 98 Mexico Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 99 Mexico Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 100 Argentina Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 101 Argentina Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 102 Argentina Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 103 Argentina Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 104 MEA Allergy Diagnostics & Therapeutics Market, By Country, 2018-2030 (USD Million)
Table 105 MEA Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 106 MEA Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 107 MEA Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 108 MEA Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 109 South Africa Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 110 South Africa Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 111 South Africa Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 112 South Africa Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 113 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 114 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 115 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 116 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 117 UAE Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 118 UAE Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 119 UAE Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 120 UAE Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
Table 121 Kuwait Allergy Diagnostics & Therapeutics Market, By Type, 2018-2030 (USD Million)
Table 122 Kuwait Allergy Diagnostics & Therapeutics Market, By Allergen type, 2018-2030 (USD Million)
Table 123 Kuwait Allergy Diagnostics & Therapeutics Market, By Food Allergen type, 2018-2030 (USD Million)
Table 124 Kuwait Allergy Diagnostics & Therapeutics Market, By Test Type, 2018-2030 (USD Million)
List of Figures
Figure 1 Allergy Diagnostics & Therapeutics Market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modelling for market share assessment.
Figure 8 Market formulation & validation
Figure 9 Allergy Diagnostics & Therapeutics Market snapshot
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook.
Figure 12 Penetration and growth prospect mapping
Figure 13 Allergy Diagnostics & Therapeutics Market driver impact
Figure 14 Allergy Diagnostics & Therapeutics Market restraint impact
Figure 15 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 16 Industry Analysis - Porter's
Figure 17 Strategy mapping
Figure 18 Allergy Diagnostics & Therapeutics Market: Type outlook and key takeaways
Figure 19 Allergy Diagnostics & Therapeutics Market: Type movement analysis & market share 2023 & 2030
Figure 20 Diagnostics Market estimates and forecast, 2018-2030 (USD Million)
Figure 21 Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 22 Instruments market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Consumable market estimates and forecast, 2018-2030 (USD Million)
Figure 24 Services market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Antihistamines Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 26 Angiotensin 2 Receptor Blockers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 27 Decongestants Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Corticosteroids Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Mast Cell Stabilizers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Leukotriene Inhibitors Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Nasal Anti-cholinergic Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Immuno-modulators Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 33 Epinephrine Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Immunotherapy Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Allergy Diagnostics & Therapeutics Market: Allergen Type outlook and key takeaways
Figure 36 Allergy Diagnostics & Therapeutics Market: Allergen Type movement analysis & market share 2023 & 2030
Figure 37 Food market estimates and forecast, 2018-2030 (USD Million)
Figure 38 Dairy Products market estimates and forecast, 2018-2030 (USD Million)
Figure 39 Poultry Product market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Tree Nuts market estimates and forecast, 2018-2030 (USD Million)
Figure 41 Peanuts market estimates and forecast, 2018-2030 (USD Million)
Figure 42 Shellfish market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Wheat market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Soy market estimates and forecast, 2018-2030 (USD Million)
Figure 45 Other Food Allergens market estimates and forecast, 2018-2030 (USD Million)
Figure 46 Inhaled market estimates and forecast, 2018-2030 (USD Million)
Figure 47 Drug market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 49 Allergy Diagnostics & Therapeutics Market: Test Type outlook and key takeaways
Figure 50 Allergy Diagnostics & Therapeutics Market: Test Type movement analysis & market share 2023 & 2030
Figure 51 In vivo Test market estimates and forecast, 2018-2030 (USD Million)
Figure 52 Skin Prick Test market estimates and forecast, 2018-2030 (USD Million)
Figure 53 Intradermal Test market estimates and forecast, 2018-2030 (USD Million)
Figure 54 Patch Test market estimates and forecast, 2018-2030 (USD Million)
Figure 55 In Vitro Test market estimates and forecast, 2018-2030 (USD Million)
Figure 56 Allergy Diagnostics & Therapeutics Market: Regional outlook and key takeaways
Figure 57 Regional outlook, 2023 & 2030
Figure 58 North America
Figure 59 North America market estimates and forecast, 2018-2030 (USD Million)
Figure 60 U.S. key country dynamics
Figure 61 U.S. market estimates and forecast, 2018-2030 (USD Million)
Figure 62 Canada key country dynamics
Figure 63 Canada market estimates and forecast, 2018-2030 (USD Million)
Figure 64 Europe
Figure 65 Europe market estimates and forecast, 2018-2030 (USD Million)
Figure 66 UK key country dynamics
Figure 67 UK market estimates and forecast, 2018-2030 (USD Million)
Figure 68 Germany
Figure 69 Germany market estimates and forecast, 2018-2030 (USD Million)
Figure 70 France key country dynamics
Figure 71 France market estimates and forecast, 2018-2030 (USD Million)
Figure 72 Italy key country dynamics
Figure 73 Italy market estimates and forecast, 2018-2030 (USD Million)
Figure 74 Spain key country dynamics
Figure 75 Spain market estimates and forecast, 2018-2030 (USD Million)
Figure 76 Denmark key country dynamics
Figure 77 Denmark market estimates and forecast, 2018-2030 (USD Million)
Figure 78 Sweden key country dynamics
Figure 79 Sweden market estimates and forecast, 2018-2030 (USD Million)
Figure 80 Norway key country dynamics
Figure 81 Norway market estimates and forecast, 2018-2030 (USD Million)
Figure 82 Asia-Pacific
Figure 83 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Figure 84 Japan key country dynamics
Figure 85 Japan market estimates and forecast, 2018-2030(USD Million)
Figure 86 China key country dynamics
Figure 87 China market estimates and forecast, 2018-2030 (USD Million)
Figure 88 India key country dynamics
Figure 89 India market estimates and forecast, 2018-2030 (USD Million)
Figure 90 South Korea key country dynamics
Figure 91 South Korea market estimates and forecast, 2018-2030 (USD Million)
Figure 92 Australia key country dynamics
Figure 93 Australia market estimates and forecast, 2018-2030 (USD Million)
Figure 94 Thailand key country dynamics
Figure 95 Thailand market estimates and forecast, 2018-2030 (USD Million)
Figure 96 Latin America
Figure 97 Latin America market estimates and forecast, 2018-2030 (USD Million)
Figure 98 Brazil key country dynamics
Figure 99 Brazil market estimates and forecast, 2018-2030 (USD Million)
Figure 100 Mexico key country dynamics
Figure 101 Mexico market estimates and forecast, 2018-2030 (USD Million)
Figure 102 Argentina key country dynamics
Figure 103 Argentina market estimates and forecast, 2018-2030 (USD Million)
Figure 104 Middle East & Africa
Figure 105 MEA market estimates and forecast, 2018-2030 (USD Million)
Figure 106 South Africa key country dynamics
Figure 107 South Africa market estimates and forecast, 2018-2030 (USD Million)
Figure 108 Saudi Arabia key country dynamics
Figure 109 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Figure 110 UAE key country dynamics
Figure 111 UAE market estimates and forecast, 2018-2030 (USD Million)
Figure 112 Kuwait key country dynamics
Figure 113 Kuwait market estimates and forecast, 2018-2030 (USD Million)
Figure 114 Market differentiators
Figure 115 Key company market share analysis, 2023
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modelling for market share assessment.
Figure 8 Market formulation & validation
Figure 9 Allergy Diagnostics & Therapeutics Market snapshot
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook.
Figure 12 Penetration and growth prospect mapping
Figure 13 Allergy Diagnostics & Therapeutics Market driver impact
Figure 14 Allergy Diagnostics & Therapeutics Market restraint impact
Figure 15 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 16 Industry Analysis - Porter's
Figure 17 Strategy mapping
Figure 18 Allergy Diagnostics & Therapeutics Market: Type outlook and key takeaways
Figure 19 Allergy Diagnostics & Therapeutics Market: Type movement analysis & market share 2023 & 2030
Figure 20 Diagnostics Market estimates and forecast, 2018-2030 (USD Million)
Figure 21 Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 22 Instruments market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Consumable market estimates and forecast, 2018-2030 (USD Million)
Figure 24 Services market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Antihistamines Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 26 Angiotensin 2 Receptor Blockers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 27 Decongestants Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Corticosteroids Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Mast Cell Stabilizers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Leukotriene Inhibitors Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Nasal Anti-cholinergic Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Immuno-modulators Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 33 Epinephrine Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Immunotherapy Allergy Diagnostics & Therapeutics Market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Allergy Diagnostics & Therapeutics Market: Allergen Type outlook and key takeaways
Figure 36 Allergy Diagnostics & Therapeutics Market: Allergen Type movement analysis & market share 2023 & 2030
Figure 37 Food market estimates and forecast, 2018-2030 (USD Million)
Figure 38 Dairy Products market estimates and forecast, 2018-2030 (USD Million)
Figure 39 Poultry Product market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Tree Nuts market estimates and forecast, 2018-2030 (USD Million)
Figure 41 Peanuts market estimates and forecast, 2018-2030 (USD Million)
Figure 42 Shellfish market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Wheat market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Soy market estimates and forecast, 2018-2030 (USD Million)
Figure 45 Other Food Allergens market estimates and forecast, 2018-2030 (USD Million)
Figure 46 Inhaled market estimates and forecast, 2018-2030 (USD Million)
Figure 47 Drug market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 49 Allergy Diagnostics & Therapeutics Market: Test Type outlook and key takeaways
Figure 50 Allergy Diagnostics & Therapeutics Market: Test Type movement analysis & market share 2023 & 2030
Figure 51 In vivo Test market estimates and forecast, 2018-2030 (USD Million)
Figure 52 Skin Prick Test market estimates and forecast, 2018-2030 (USD Million)
Figure 53 Intradermal Test market estimates and forecast, 2018-2030 (USD Million)
Figure 54 Patch Test market estimates and forecast, 2018-2030 (USD Million)
Figure 55 In Vitro Test market estimates and forecast, 2018-2030 (USD Million)
Figure 56 Allergy Diagnostics & Therapeutics Market: Regional outlook and key takeaways
Figure 57 Regional outlook, 2023 & 2030
Figure 58 North America
Figure 59 North America market estimates and forecast, 2018-2030 (USD Million)
Figure 60 U.S. key country dynamics
Figure 61 U.S. market estimates and forecast, 2018-2030 (USD Million)
Figure 62 Canada key country dynamics
Figure 63 Canada market estimates and forecast, 2018-2030 (USD Million)
Figure 64 Europe
Figure 65 Europe market estimates and forecast, 2018-2030 (USD Million)
Figure 66 UK key country dynamics
Figure 67 UK market estimates and forecast, 2018-2030 (USD Million)
Figure 68 Germany
Figure 69 Germany market estimates and forecast, 2018-2030 (USD Million)
Figure 70 France key country dynamics
Figure 71 France market estimates and forecast, 2018-2030 (USD Million)
Figure 72 Italy key country dynamics
Figure 73 Italy market estimates and forecast, 2018-2030 (USD Million)
Figure 74 Spain key country dynamics
Figure 75 Spain market estimates and forecast, 2018-2030 (USD Million)
Figure 76 Denmark key country dynamics
Figure 77 Denmark market estimates and forecast, 2018-2030 (USD Million)
Figure 78 Sweden key country dynamics
Figure 79 Sweden market estimates and forecast, 2018-2030 (USD Million)
Figure 80 Norway key country dynamics
Figure 81 Norway market estimates and forecast, 2018-2030 (USD Million)
Figure 82 Asia-Pacific
Figure 83 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Figure 84 Japan key country dynamics
Figure 85 Japan market estimates and forecast, 2018-2030(USD Million)
Figure 86 China key country dynamics
Figure 87 China market estimates and forecast, 2018-2030 (USD Million)
Figure 88 India key country dynamics
Figure 89 India market estimates and forecast, 2018-2030 (USD Million)
Figure 90 South Korea key country dynamics
Figure 91 South Korea market estimates and forecast, 2018-2030 (USD Million)
Figure 92 Australia key country dynamics
Figure 93 Australia market estimates and forecast, 2018-2030 (USD Million)
Figure 94 Thailand key country dynamics
Figure 95 Thailand market estimates and forecast, 2018-2030 (USD Million)
Figure 96 Latin America
Figure 97 Latin America market estimates and forecast, 2018-2030 (USD Million)
Figure 98 Brazil key country dynamics
Figure 99 Brazil market estimates and forecast, 2018-2030 (USD Million)
Figure 100 Mexico key country dynamics
Figure 101 Mexico market estimates and forecast, 2018-2030 (USD Million)
Figure 102 Argentina key country dynamics
Figure 103 Argentina market estimates and forecast, 2018-2030 (USD Million)
Figure 104 Middle East & Africa
Figure 105 MEA market estimates and forecast, 2018-2030 (USD Million)
Figure 106 South Africa key country dynamics
Figure 107 South Africa market estimates and forecast, 2018-2030 (USD Million)
Figure 108 Saudi Arabia key country dynamics
Figure 109 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Figure 110 UAE key country dynamics
Figure 111 UAE market estimates and forecast, 2018-2030 (USD Million)
Figure 112 Kuwait key country dynamics
Figure 113 Kuwait market estimates and forecast, 2018-2030 (USD Million)
Figure 114 Market differentiators
Figure 115 Key company market share analysis, 2023
Companies Mentioned
- R-Biopharm AG
- EUROIMMUN Medizinische Labordiagnostika AG
- DASIT Group SPA
- AESKU.GROUP GmbH
- bioMérieux
- Danaher
- Thermo Fisher Scientific, Inc
- Minaris Medical America, Inc.
- Siemens Healthcare GmbH
- Omega Diagnostics Group PLC
- HYCOR Biomedical
- Lincoln Diagnostics, Inc.
- Alcon
- HOB Biotech Group Corp., Ltd.
- AbbVie Inc.
- Allergy Therapeutics
- Sanofi
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- GSK plc
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Astellas Pharma Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | December 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 33.06 Billion |
| Forecasted Market Value ( USD | $ 58.31 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 7 |
